军事知识服务平台
重型再生障碍性贫血患者CD8+HLA-DR+T淋巴细胞效应因子mRNA的表达
Expression of lymphokines in CD8+ HLA-DR+ T lymphocytes of patients with severe aplastic anemia
摘要 目的 观察重型再生障碍性贫血(SAA)患者外周血CD8+ HLA-DR+T淋巴细胞效应因子水平,进一步探讨SAA的免疫发病机制.方法 采用免疫磁珠分选24例SAA初治患者及23名健康对照外周血CD8+ HLA-DR+效应T细胞,半定量反转录PCR检测分选细胞穿孔素、颗粒酶B、Fas配体(FasL)、肿瘤坏死因子β(TNF-β) mRNA表达情况.结果 SAA初治组CD8+ HLA-DR+效应T细胞的穿孔素、颗粒酶B、FasL、TNF-β mRNA的表达量分别为0.66±0.25、0.56±0.26、0.77±0.24、0.58±0.16,均明显高于健康对照(0.53±0.14、0.40±0.13、0.61±0.16、0.46±0.15,P=0.042、0.012、0.011、0.011).结论 CD8+ HLA-DR+效应T细胞可能通过穿孔素、颗粒酶B途径、Fas/FasL途径及TNF-β途径损伤SAA患者骨髓造血细胞,在SAA免疫发病过程中发挥了重要作用.
Abstract:
Objective To examine the expression of lymphokines damaging hematopoietic cells by CD8 + HLA-DR + effector T cells in peripheral blood (PB) of the patients with severe aplastic anemia (SAA)and explore further the heterogeneous immunopathogenesis of SAA.Methods The CD8+ HLA-DR+ cells were sorted by immunomagnetic separation from the PB of 24 untreated SAA patients and 23 normal controls.The mRNA expressions of perforin,granzyme B,FasL and tumor necrosis factor β (TNF-3) of sorted cells were analyzed by reverse transcription-polymerase chain reaction (RT-PCR).Results The mRNA levels of perforin,granzyme B of CD8 + HLA-DR+ T cells in untreated group were higher than those of the controls (0.66 ±0.25,0.56 ±0.26 vs 0.53 ±0.14,0.40 ±0.13,P =0.042,0.012).The mRNA level of FasL in CD8+ HLA-DR+ T cells of untreated SAA patients was higher than that of the controls (0.77 ± 0.24 vs 0.61 ±0.16,P =0.011 ).The mRNA of TNF-β in CD8 + HLA-DR+ T cells of untreated SAA patients was also higher than that of the controls (0.58 ± 0.16 vs 0.46 ± 0.15,P =0.011 ).Conclusions CD8 + HLA-DR+ T cells may damage hematopoiesis through the actions of perforin,granzyme B,TNF-β and FasL.And it thus contributes to the immunopathogenesis of SAA
Author: LIU Chun-yan FU Rong WANG Jun LIANG Yong QU Wen RUAN Er-bao WANG Hua-quan LI Li-juan LIU Hui WANG Guo-jin LIU Hong WU Yu-hong WANG Xiao-ming SONG Jia XING Li-min GUAN Jing WANG Hong-lei ZHANG Tian LIU Xiao SHAO Zong-hong
作者单位: 300052,天津医科大学总医院血液肿瘤科
刊 名 中华医学杂志 ISTICPKU
年,卷(期): 2012, 92(18)
分类号: R4
机标分类号: R733 R556 R392.3
在线出版日期: 2012年7月27日
基金项目: 30971286:国家自然科学基金201002024:卫生部卫生行业科研专项200800620004:高等学校博士学科点专项科研基金08JCYBJC07800:天津市应用基础与前沿技术研究计划11KG135:天津市卫生局科技攻关计划,